According to the American Cancer Society, prostate cancer is one of the leading types of cancer in men in the United States. An estimated 1 in 8 men will be diagnosed with the disease. Receiving a ...

Bipartisan legislation would waive prostate cancer screening cost-sharing for high-risk populations and save lives This bipartisan legislative proposal would waive cost-sharing requirements for men ...

A commercial payment incentive had at best modest effects on the adoption of prostate cancer active surveillance. A clinician payment incentive did not lead to increased adoption of active ...

Policy interventions, including insurance reform, are needed to alleviate the financial burden on patients, according to researchers. Financial distress may be more likely among survivors of ...

Androgen deprivation therapy (ADT), also called hormone therapy, is a common treatment for metastatic prostate cancer. It works by starving the cancer of testosterone, which fuels the tumor’s growth.

If you have prostate cancer, your health care provider may have told you about a medicine called Nubeqa (darolutamide). The FDA approved Nubeqa in 2019. It is commonly used to treat prostate cancer ...

After skin cancer, prostate cancer is the most commonly diagnosed cancer among men in the United States. In fact, one in eight men will be diagnosed with prostate cancer during their lifetime, ...

Pre-biopsy MRIs can help doctors diagnose and treat prostate cancer more accurately. Here’s when you should get one.

Cannabidiol (CBD) is a biologically active molecule in cannabis. Research examining the use of CBD to help treat prostate cancer is still in the early stages. Some evidence suggests that it may help ...